Home > Boards > US Listed > Biotechs > Fluidigm Corp. (FLDM)

It has been taking Companies anywhere between 2-3

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
pkdaddy64 Member Profile
 
Followed By 255
Posts 15,260
Boards Moderated 1
Alias Born 06/12/09
160x600 placeholder
Fluidigm to Offer Millions of Advanta COVID-19 Tests at Low Cost to U.S. Colleges and Universities GlobeNewswire Inc. - 10/8/2020 8:30:10 AM
Fluidigm Announces Conference Call and Webcast of Third Quarter 2020 Financial Results GlobeNewswire Inc. - 10/6/2020 4:02:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2020 6:01:42 AM
Fluidigm Joins Global Consortium of Cancer Prevention Experts GlobeNewswire Inc. - 9/16/2020 8:45:10 AM
ImmunoGenomics and Vero Diagnostics Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomar... GlobeNewswire Inc. - 9/16/2020 8:30:10 AM
Fluidigm Announces Agenda for 9th Annual Mass Cytometry Summit GlobeNewswire Inc. - 9/15/2020 8:30:10 AM
Fluidigm Achieves Initial Milestone under NIH Rapid Acceleration of Diagnostics Agreement GlobeNewswire Inc. - 9/8/2020 8:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/8/2020 6:10:43 AM
Fluidigm to Participate at the 2020 Cantor Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/2/2020 4:02:10 PM
Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR  Assay for COVID-19 GlobeNewswire Inc. - 8/25/2020 11:00:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2020 7:20:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2020 7:20:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2020 7:20:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2020 7:19:35 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2020 4:29:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2020 4:09:56 PM
Fluidigm Announces Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/6/2020 4:05:10 PM
Fluidigm and De Novo Software to Offer Mass Cytometry Customers a Streamlined Solution for Data Analysis GlobeNewswire Inc. - 8/4/2020 8:30:10 AM
Fluidigm Selected for $37 Million Project under National Institutes of Health RADx Initiative GlobeNewswire Inc. - 7/31/2020 11:10:10 AM
GnomeDX Files for FDA Emergency Use Authorization for Rapid Turnaround Real-Time RT-PCR COVID-19 Test Utilizing the Fluidigm ... GlobeNewswire Inc. - 7/20/2020 8:30:10 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 7/10/2020 4:39:01 PM
Fluidigm Announces Conference Call and Webcast of Second Quarter 2020 Financial Results GlobeNewswire Inc. - 7/6/2020 4:02:10 PM
Multi-Site Study of COVID-19 Patients Utilizing Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay GlobeNewswire Inc. - 6/29/2020 8:30:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2020 4:01:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2020 4:00:53 PM
pkdaddy64   Sunday, 06/14/20 08:43:58 AM
Re: cityimport post# 338
Post # of 595 
It has been taking Companies anywhere between 2-3 weeks for approval.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences